• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AHA Post Conference Perspectives: Emerging Therapies in Hypertrophic Cardiomyopathy (HCM)

home / post-conference-perspectives / aha-post-conference-perspectives-emerging-therapies-in-hypertrophic-cardiomyopathy-hcm-

An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.

© 2024 MJH Life Sciences
All rights reserved.